We only have this paper's title and publication details.
Read it at the sourceSTAR*D's cumulative remission rate was approximately half of that reported.
No takes yet. Share an insight, caveat, or question.
Pigott et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: